We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00481039
First Posted: June 1, 2007
Last Update Posted: September 4, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
HaEmek Medical Center, Israel
  Purpose

Sickle cell anemia and sickle cell thalassemia are frequent diseases among the israeli arab population. The purpose of this study is to assess the clinical characteristics of the patients in one arab village and the laboratory characteristics in the carriers of this gene based in the screening for pregnant women that is carried out in the population of northern Israel.

The results can be useful in order to institute universal screening for sickle cell anemia in northern Israel.


Condition Intervention
Sickle Cell Disease Procedure: Medical history and basic laboratory analysis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel- An Observational Study

Resource links provided by NLM:


Further study details as provided by HaEmek Medical Center, Israel:

Estimated Enrollment: 300
Study Start Date: May 2007
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Patients diagnosed as having abnormal hemoglobin like hemoglobin S and thalassemia in a bedouin village
Procedure: Medical history and basic laboratory analysis
Medical history and basic laboratory analysis

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All the patients diagnosed with abnormal hemoglobin in the bedouin arab village
Criteria

Inclusion Criteria:

  • All the patients that were diagnosed as having sickle cell disease in the specific village and all the population screened for hemoglobinopathies in the same location
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00481039


Locations
Israel
Pediatric Hematology Unit - HaEmek Medical Center
Afula, Israel, 18101
Sponsors and Collaborators
HaEmek Medical Center, Israel
Investigators
Study Director: Ariel Koren, MD Pediatric Hematology Unit, Ha'Emek Medical Center
Study Chair: luci Zalman, Phd Hematology Laboratory - HaEmek Medical Center
Principal Investigator: Tania Flaishman, Student Pediatric Dpt B - Ha'Emek Medical Center
  More Information

Responsible Party: Dr Koren Ariel, Pediatric Hematology Unit - Ha'Emek Medical Center
ClinicalTrials.gov Identifier: NCT00481039     History of Changes
Other Study ID Numbers: 5311006.EMC
First Submitted: May 31, 2007
First Posted: June 1, 2007
Last Update Posted: September 4, 2009
Last Verified: September 2009

Keywords provided by HaEmek Medical Center, Israel:
Sickle cell disease
Sickle cell thalassemia
Population screening

Additional relevant MeSH terms:
Anemia, Sickle Cell
Anemia, Hemolytic, Congenital
Anemia, Hemolytic
Anemia
Hematologic Diseases
Hemoglobinopathies
Genetic Diseases, Inborn